Findings
========

Typical characteristics for the lactation phase are dramatic increases in the energy and nutrient requirement of the organism, which are usually met by an elevation of food intake and a mobilisation of body's energy stores \[[@B1],[@B2]\]. In dairy cows, lactation was also shown to induce immune and inflammatory responses in the liver \[[@B3],[@B4]\]. In contrast to extensive research in rodents and cows on the mechanisms underlying the lactation-induced metabolic and immunologic adaptations \[[@B3]-[@B6]\], only limited information is available in sows in this regard \[[@B7],[@B8]\]. In an attempt to improve the knowledge about metabolic and immunologic adaptations during lactation in sows we have recently analyzed the changes in the hepatic transcriptome of sows during lactation on a genome-wide level \[[@B9]\]. Besides the expected induction of energy-generating pathways in the liver during lactation, we found that lactation causes an induction of an inflammatory state as evidenced from the marked induction of several acute phase proteins in the liver of lactating sows \[[@B9]\]. Acute phase proteins are secreted from hepatocytes in response to inflammatory stimuli and are therefore established markers of inflammation in both human and veterinary clinical pathologies, which indicates that lactation induces an inflammatory state in the liver of sows, like in dairy cows \[[@B3],[@B4]\]. Interestingly, we have recently reported that the inflammatory state in the liver of dairy cows during lactation is accompanied by activation of the nuclear factor E2-related factor 2 (Nrf2) stress signalling pathway (unpublished observations). Nrf2 is a redox-sensitive transcription factor which upon activation by inflammatory stimuli but also reactive oxygen species (ROS), xenobiotics or electrophiles \[[@B10]\] induces the transcription of a large set of genes encoding various antioxidative proteins such as glutathione peroxidase 1 (encoded by *GPX1*), superoxide dismutase (encoded by *SOD*) and cytoprotective proteins \[heme oxygenase 1 (encoded by *HO-1*), NAD(P)H dehydrogenase, quinone 1 (encoded by *NQO1*), peroxiredoxin 6 (encoded by *PRDX6*), thioredoxin reductase 1 (encoded by *TXNRD1*), glucuronosyltransferase 1 family, polypeptide A1 (encoded by *UGT1A1*)\] and thereby protects tissues from inflammatory damage and neutralizes ROS produced under pro-inflammatory conditions \[[@B11]\]. In light of the observation that the lactation-induced inflammatory state in the liver of dairy cows is accompanied by activation of the Nrf2 pathway and in order to further improve knowledge about the mechanisms underlying the lactation-induced adaptations during lactation in sows, the present study aimed to investigate whether the Nrf2 pathway is activated in the liver of lactating sows.

The animal study was carried out in accordance with established guidelines for the care and handling of laboratory animals and was approved by the local Animal Welfare Authorities (Regierungspräsidium Giessen; permission no: GI 19/3-No. 29/2010). As described recently in more detail \[[@B9]\], the experiment was performed with twenty second parity sows (Large White & German Landrace), which were artificially inseminated with semen from boars of the own breed, and kept in single crates until day 21 of pregnancy. From day 21 to 110 of pregnancy, the sows were kept in groups in pens that had fully slatted floors, nipple drinkers and feeding stations. On day 110 of pregnancy, they were moved to the farrowing accommodation where they were housed in single farrowing pens. Throughout pregnancy, sows of both groups were fed a commercial diet for gestating sows *ad libitum*. After farrowing, the sows were randomly assigned into two groups of 10 animals each. In the first group of sows, all piglets were removed from the sow ("non-lactating group") 24 h after parturition. This group served as the non-lactating control. In the second group, litters were standardised to 12 piglets per sow ("lactating group"). Throughout lactation until the end of the experiment the sows received a diet for lactating sows. Until day 6 after farrowing, the amount of feed given to the lactating sows was successively increased, and from day 7 after farrowing and thereafter the sows were fed individual amounts of feed depending on their body weights. In the non-lactating group, each sow received an amount of food sufficient to cover the individual energy and nutrient requirement for maintenance. On day 20 after farrowing, liver tissue was taken by biopsy and blood was collected from *Vena jugularis*. A full description of the housing condition, diet composition, feeding regime and sample collection including biopsy sample procedure can be found in our recent publication \[[@B9]\]. RNA isolation from frozen liver biopsies and quantitative real-time PCR (qPCR) analysis were performed as described recently in detail by Keller *et al.*\[[@B12]\]. Characteristics of primers and primer performance data used for qPCR analysis are shown in Table [1](#T1){ref-type="table"}. Plasma levels of TBARS were measured in plasma using a modified version of the TBARS assay \[[@B13]\]. Statistical analysis was performed by one way analysis of variance. Fisher's multiple range test was used to generate significant F-values of differences with *P* \< 0.05.

###### 

Characteristics of primers and primer performance data used for qPCR

  **Gene symbol**     **Forward primer (from 5' to 3')**           **Product size (bp)**   **NCBI GenBank**   **Slope**   **R2**^**\#**^   **Efficiency\***  **M**
  ------------------- ------------------------------------------- ----------------------- ------------------ ----------- ---------------- ------------------ -------
  *Reference genes*                                                                                                                                          
  RSP9                GTCGCAAGACTTATGTGACC                                  325              XM_003356050       -0.28         0.999              1.91        0.053
                      AGCTTAAAGACCTGGGTCT                                                                                                                     
  ATP5G1              CAGTCACCTTGAGCCGGGCA                                  94               NM_001025218       -0.30         0.998              1.99        0.054
                      TAGCGCCCCGGTGGTTTGC                                                                                                                     
  GSR                 AGCGCGATGCCTACGTGAGC                                  175                AY368271         -0.29         0.997              1.94        0.055
                      GGTACGCCGCCTGTGGCAAT                                                                                                                    
  ACTB                GACATCCGCAAGGACCTCTA                                  205              XM_003124280       -0.32         0.992              2.1         0.064
                      ACATCTGCTGGAAGGTGGAC                                                                                                                    
  SHAS2               GAAAAGGCTAACCTACCCTG                                  218               NM_214053         -0.21         0.996              1.65        0.076
                      TGTTGGACAAGACCAGTTGG                                                                                                                    
  *Target genes*                                                                                                                                             
  HP                  ACAGATGACAGCTGCCCAAA                                  188               NM_214000         -0.30         0.997              1.99         
                      CCGCACACTGCTTCACATTC                                                                                                                    
  FGG                 GACATCTGTCTCCTACTGGA                                  375              NM_001244524       -0.29         0.999              1.95         
                      CATGACACTTGTTCATCCAC                                                                                                                    
  CFB                 CTCAACGCAAAGACCGCAAA                                  106              NM_001101824       -0.29         0.998              1.96         
                      AAATGGGCCTGATGGTCTGG                                                                                                                    
  CRP                 CCTTTGTCTTCCCCAAAGAG                                  563               NM_213844         -0.28         0.999              1.91         
                      CACCTCGCCACTCATTTCAT                                                                                                                    
  LBP                 ACCGCTCCCCAGTTGGCTTC                                  406              NM_001128435       -0.29         0.999              1.96         
                      AGCGCGGCGGACACATTAGT                                                                                                                    
  NQO1                CCAGCAGCCCGGCCAATCTG                                  160              NM_001159613       -0.28         0.997              1.89         
                      AGGTCCGACACGGCGACCTC                                                                                                                    
  TXNRD1              CTTTACCTTATTGCCCGGGT                                  162               NM_214154         -0.30         0.999              1.98         
                      GTTCACCGATTTTGTTGGCC                                                                                                                    
  UGT1A1              GATCCTTTCCTGCAACGCAT                                  313              XM_003483776       -0.28         0.996              1.91         
                      GGAAGGTCATGTGATCTGAG                                                                                                                    
  HO-1                AGCTGTTTCTGAGCCTCCAA                                  130              NM_001004027       -0.30         0.998              1.98         
                      CAAGACGGAAACACGAGACA                                                                                                                    
  PRDX6               GGCCGCATCCGTTTCCACGA                                  280               NM_214408         -0.29         0.998              1.95         
                      ACTGGATGGCAAGGTCCCGACT                                                                                                                  
  SOD                 TCCATGTCCATCAGTTTGGA                                  250              NM_001190422       -0.27         0.998              1.88         
                      CTGCCCAAGTCATCTGGTTT                                                                                                                    
  GPX1                GGCACAACGGTGCGGGACTA AGGCGAAGAGCGGGTGAGCA             235               NM_214201         -0.29         0.998              1.96         

^\#^Coefficient of determination of the standard curve. \*The efficiency is determined by \[10^-slope^\].

Abbreviations: *RSP9* 40S ribosomal protein S9-like, *ATP5G1* ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9), *GSR* glutathione reductase, *ACTB* actin, beta, *SHAS2* hyaluronan synthase 2, *HP* haptoglobin, *FGG* fibrinogen γ, *CFB* complement factor B, *CRP* C-reactive protein, *LBP* lipopolysaccharide-binding protein, *NQO1* NAD(P)H dehydrogenase, quinone 1, *TXNRD1* thioredoxin reductase 1, *UGT1A1* glucuronosyltransferase 1 family, and polypeptide *A1; HO-1* heme oxygenase 1, *PRDX6* peroxiredoxin 6, *SOD* superoxide dismutase, *GPX1* glutathione peroxidase 1.

As expected, evaluation of body weight development of sows throughout lactation revealed that sows of both groups lost body weight but that body weight loss was greater in lactating than in non-lactating sows despite the fact that lactating sows had a markedly greater feed intake \[[@B9]\]. Estimation of the energy balance of the sows revealed that lactating sows are in a strong negative energy balance during lactation indicating that the increased feed intake was not sufficient to fully compensate the body weight loss. In order to evaluate activation of Nrf2 pathway in the liver of sows we determined transcript levels of several known Nrf2 target genes in the liver samples. The results of the present study clearly show that the transcript levels of known Nrf2 target genes, *UGT1A1*, *HO-1*, *NQO1*, *GPX1*, *PRDX6*, *TXNRD1*, and *SOD*, in the liver are markedly elevated (between 1.7 and 3.1 fold) in lactating sows compared to non-lactating sows (*P* \< 0.05, Table [2](#T2){ref-type="table"}). Given that the above mentioned genes contain functional antioxidant response elements (ARE), which are the DNA binding motifs for Nrf2, in their regulatory regions \[[@B14]\], the up-regulation of these genes during lactation indicates, at least indirectly, that the Nrf2 pathway is indeed activated in the liver of lactating sows. This is in line with recent observations in dairy cows in which the Nrf2 pathway was shown to be strongly activated in liver (unpublished observations) and spleen \[[@B15]\] in early lactation compared to late pregnancy. Due to the limited amount of liver tissue obtained from the biopsy sampling procedure additional assays, such as gel-shift assays providing direct evidence for activation of Nrf2 through determining of binding of Nrf2 to the ARE motif of Nrf2 target genes, could not be conducted. Due to the same reason protein levels of the Nrf2 target genes were not determined. However, several studies clearly showed that increased mRNA levels of Nrf2 target genes positively correlate with elevated levels of the encoded proteins \[[@B16],[@B17]\], suggesting that elevated Nrf2 target gene levels are suitable indicators of Nrf2 activation.

###### 

Relative transcript levels of Nrf2 target genes in the liver of lactating and non-lactating sows on day 20 of lactation

            **Non-lactating (n = 10)**   **Lactating (n = 10)**   ***P*value**
  -------- ---------------------------- ------------------------ --------------
  UGT1A1             1 ± 0.52                1.79 ± 0.59\*           0.013
  HO-1               1 ± 0.48                1.71 ± 0.42\*           0.007
  NQO1               1 ± 0.49                2.91 ± 1.54\*           0.007
  GPX1               1 ± 0.56                3.11 ± 1.19\*           0.001
  PRDX6              1 ± 0.56                2.12 ± 0.78\*           0.008
  TXNRD1             1 ± 0.28                2.99 ± 2.45\*           0.029
  SOD                1 ± 0.65                2.28 ± 1.01\*           0.007
  MT1A               1 ± 0.37                 1.64 ± 1.26            0.190

Values represent mean ± SD for n = 10 sows per group. \*Significantly different from non-lactating group (*P* \< 0.05).

With regard to the mechanism underlying the activation of Nrf2 during lactation, it may be speculated that ROS, which are known activators of Nrf2 \[[@B10]\] and generated during an inflammatory process and an elevated energy production through the respiratory chain, are the stimuli triggering the activation of Nrf2 in the liver during lactation. Transcript levels of genes encoding acute phase proteins, such as haptoglobin (encoded by *HP*), fibrinogen γ (encoded by *FGG*), complement factor B (encoded by *CFB*), C-reactive protein (encoded by *CRP*) and lipopolysaccharide-binding protein (encoded by *LBP*), were clearly higher (2 to 8.7 fold) in lactating compared to non-lactating sows (*P* \< 0.05, Table [3](#T3){ref-type="table"}) providing at least indirect evidence for an inflammatory state occurring in the liver of lactating sows. In addition, the recently observed induction of energy-generating pathways (fatty acid catabolism, tricarboxylic acid cycle, respiratory chain) in livers of lactating sows \[[@B9]\] is supportive for an elevated energy production during lactation. The unaltered plasma levels of TBARS, which were used as markers of oxidative stress, between lactating and non-lactating sows in the present study (7.03 ± 1.54 vs. 7.02 ± 2.25 nmol/μmol triacylglycerols, n = 10/group, *P* \> 0.05) suggests at first glance that ROS production was not elevated in sows during lactation. However, the lack of an increase in TBARS levels may be simply explained by the up-regulation of antioxidant genes which likely improved the capacity of the liver to cope with the increased levels of ROS and to prevent oxidative stress.

###### 

Relative transcript levels of genes encoding acute phase proteins in the liver of lactating and non-lactating sows on day 20 of lactation

         **Non-lactating (n = 10)**   **Lactating (n = 10)**   ***P*value**
  ----- ---------------------------- ------------------------ --------------
  HP              1 ± 0.89                2.58 ± 1.08\*           0.005
  FGG             1 ± 0.55                2.90 ± 0.66\*           0.001
  CFB             1 ± 0.52                2.01 ± 0.36\*           0.001
  CRP             1 ± 0.68                8.68 ± 4.20\*           0.001
  LBP             1 ± 0.71                5.82 ± 1.94\*           0.001

Values represent mean ± SD for n = 10 sows per group. \*Significantly different from non-lactating group (*P* \< 0.05).

In conclusion, the results of the present study indicate that the Nrf2 pathway in the liver of sows is activated during lactation. The activation of Nrf2 pathway during lactation in sows might be interpreted as a physiologic means to counteract the inflammatory process and to protect the liver against damage induced by inflammatory signals and ROS, which are released at elevated levels as a consequence of the metabolic and immunologic adaptations occurring during the transition from pregnancy to lactation (Figure [1](#F1){ref-type="fig"}). Since Nrf2 is also expressed in the mammary gland, which is particularly susceptible for the induction of an inflammatory state caused by bacterial invasion via the mammary gland \[[@B18]\], it is likely that activation of this pathway during lactation might provide protection against bacterial derived inflammatory stimuli also in non-hepatic tissues.

![**Activation of stress signalling pathways in the liver of sows during lactation.** Activation of Nrf2 and NF-κB during lactation is mediated by various stimuli including reactive oxygen species (ROS), bacterial lipopolysaccharide (LPS) and cytokines, which are known activators of both, Nrf2 and NF-κB. Activation of Nrf2 leads to up-regulation of classical Nrf2 target genes such as glutathione peroxidase 1 (encoded by *GPX1*), superoxide dismutase (encoded by *SOD*) and cytoprotective proteins \[heme oxygenase 1 (encoded by *HO-1*), NAD(P)H dehydrogenase, quinone 1 (encoded by *NQO1*), peroxiredoxin 6 (encoded by *PRDX6*), thioredoxin reductase 1 (encoded by *TXNRD1*), glucuronosyltransferase 1 family, and polypeptide A1 (encoded by *UGT1A1*)\]. Acivation of NF-κB results in the induction of acute phase proteins such as haptoglobin (encoded by *HP*), fibrinogen γ (encoded by *FGG*), complement factor B (encoded by *CFB*), C-reactive protein (encoded by *CRP*) and lipopolysaccharide-binding protein (encoded by *LBP*). Activation of stress signalling pathways during lactation in sows might be interpreted as a physiologic means to counteract the inflammatory process and to protect the liver against deleterious effects of inflammatory signals and ROS, which are released at elevated levels as a consequence of the metabolic and immunologic adaptations occurring during the transition from pregnancy to lactation.](1751-0147-54-59-1){#F1}
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